| HLA-A*03:01&B2M&KRAS G12V (VVGAVGVGK) Monomer [Gly25-Thr305 (HLA-A*03:01), Ile21-Met119 (B2M) and VVGAVGVGK peptide] Accession # NP_002107.3(HLA-A*03:01)&P61769(B2M)&VVGAVGVGK | His | Avi |
| N-term | C-term |
[4 Images]
| 规格 | 价 格(¥) | 数量 | |
| ¥4500 |
| HLA-C*03:04&B2M&KRAS G12D (GADGVGKSAL) Monomer [Gly25-Thr305(HLA-C*03:04), Ile21-Met119(B2M) and GADGVGKSAL peptide] Accession # QAV56463.1(HLA-C*03:04)&P61769(B2M)&GADGVGKSAL | His | Avi |
| N-term | C-term |
[4 Images]
| 规格 | 价 格(¥) | 数量 | |
| ¥4500 |
| HLA-A*11:01&B2M&KRAS G12A (VVVGAAGVGK) Monomer [Gly25-Thr305(HLA-A*11:01), Ile21-Met119(B2M) and VVVGAAGVGK peptide] Accession # AAV53343.1(HLA-A*11:01)&P61769(B2M)&VVVGAAGVGK | His | Avi |
| N-term | C-term |
[4 Images]
| 规格 | 价 格(¥) | 数量 | |
| ¥4500 |
| HLA-A*11:01&B2M&KRAS G12R (VVVGARGVGK) Tetramer[Gly25-Thr305(HLA-A*11:01), Ile21-Met119(B2M) and VVVGARGVGK peptide] Accession # AAV53343.1(HLA-A*11:01)&P61769(B2M)&VVVGARGVGK | His | Avi |
| N-term | C-term |
[4 Images]
| 规格 | 价 格(¥) | 数量 | |
| ¥9900 |
| HLA-A*11:01&B2M&KRAS G12C (VVVGACGVGK) Tetramer[Gly25-Thr305(HLA-A*11:01), Ile21-Met119(B2M) and VVVGACGVGK peptide] Accession # AAV53343.1(HLA-A*11:01)&P61769(B2M)&VVVGACGVGK | His | Avi |
| N-term | C-term |
[4 Images]
| 规格 | 价 格(¥) | 数量 | |
| ¥9900 |
| HLA-C*03:04&B2M&KRAS G12D (GADGVGKSAL) Tetramer[Gly25-Thr305 (HLA-C 03:04), Ile21-Met119 (B2M) and GADGVGKSAL peptide] Accession # QAV56463.1(HLA-C*03:04)&P61769(B2M)&GADGVGKSAL | His | Avi |
| N-term | C-term |
[4 Images]
| 规格 | 价 格(¥) | 数量 | |
| ¥9900 |
| TGF-β1 (Ala279-Ser390) Accession # P18341 |
[7 Images]
| 规格 | 价 格(¥) | 数量 | |
| ¥1200 |
| TNFR2/CD120b/TNFRSF1B (Leu23-Asp257) Accession # A0A2K5VEV7 | His |
| N-term | C-term |
[6 Images]
| 规格 | 价 格(¥) | 数量 | |
| ¥2600 |
[1 Image]
| 规格 | 价 格(¥) | 数量 | |
| ¥350 |
| PDGF-DD (Ser250-Arg370) Accession # Q9GZP0 |
[3 Images]
| 规格 | 价 格(¥) | 数量 | |
| ¥600 |